KEFEA: Re-elected president
Pfizers Cyprus Business Manager Kyriakos Mikellis has been re-elected for the next two years as president of the Cyprus Association of Research and Development Pharmaceutical Companies (KEFEA).
Mikellis stressed that KEFEAs priorities in the near future will be the implementation of a viable and effective National Health Scheme in Cyprus and the realisation of European directive and falsified medicines. Jacqueline Anastassiades, Managing Director of Merck Sharp & Dohme (MSD) in Cyprus, was elected as vice president.
KEFEA, founded in 2006, represents the pharmaceutical industry in Cyprus with the aim to implement a sustainable healthcare system for all Cypriots. Its members are relevant healthcare stakeholders.
NOD-Proteindesign.Andreas Heddergott/TUM.jpg
Certest
Consilium